BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 19307990)

  • 1. The immune tolerance of cancer is mediated by IDO that is inhibited by COX-2 inhibitors through regulatory T cells.
    Lee SY; Choi HK; Lee KJ; Jung JY; Hur GY; Jung KH; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Yoo SH
    J Immunother; 2009 Jan; 32(1):22-8. PubMed ID: 19307990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer.
    Sharma S; Yang SC; Zhu L; Reckamp K; Gardner B; Baratelli F; Huang M; Batra RK; Dubinett SM
    Cancer Res; 2005 Jun; 65(12):5211-20. PubMed ID: 15958566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steady state dendritic cells with forced IDO expression induce skin allograft tolerance by upregulation of regulatory T cells.
    Yu G; Fang M; Gong M; Liu L; Zhong J; Feng W; Xiong P; Wang CY; Gong F
    Transpl Immunol; 2008 Jan; 18(3):208-19. PubMed ID: 18047928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperexpression of cyclooxygenase 2 in the lupus immune system and effect of cyclooxygenase 2 inhibitor diet therapy in a murine model of systemic lupus erythematosus.
    Zhang L; Bertucci AM; Smith KA; Xu L; Datta SK
    Arthritis Rheum; 2007 Dec; 56(12):4132-41. PubMed ID: 18050205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neem leaf glycoprotein overcomes indoleamine 2,3 dioxygenase mediated tolerance in dendritic cells by attenuating hyperactive regulatory T cells in cervical cancer stage IIIB patients.
    Roy S; Barik S; Banerjee S; Bhuniya A; Pal S; Basu P; Biswas J; Goswami S; Chakraborty T; Bose A; Baral R
    Hum Immunol; 2013 Aug; 74(8):1015-23. PubMed ID: 23628394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut CD103+ dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction.
    Matteoli G; Mazzini E; Iliev ID; Mileti E; Fallarino F; Puccetti P; Chieppa M; Rescigno M
    Gut; 2010 May; 59(5):595-604. PubMed ID: 20427394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (-)-Epigallocatechin gallate suppresses indoleamine 2,3-dioxygenase expression in murine dendritic cells: evidences for the COX-2 and STAT1 as potential targets.
    Jeong YI; Jung ID; Lee JS; Lee CM; Lee JD; Park YM
    Biochem Biophys Res Commun; 2007 Mar; 354(4):1004-9. PubMed ID: 17270146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutive expression of IDO by dendritic cells of mesenteric lymph nodes: functional involvement of the CTLA-4/B7 and CCL22/CCR4 interactions.
    Onodera T; Jang MH; Guo Z; Yamasaki M; Hirata T; Bai Z; Tsuji NM; Nagakubo D; Yoshie O; Sakaguchi S; Takikawa O; Miyasaka M
    J Immunol; 2009 Nov; 183(9):5608-14. PubMed ID: 19843945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel cancer therapy by skin delivery of indoleamine 2,3-dioxygenase siRNA.
    Yen MC; Lin CC; Chen YL; Huang SS; Yang HJ; Chang CP; Lei HY; Lai MD
    Clin Cancer Res; 2009 Jan; 15(2):641-9. PubMed ID: 19147770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene delivery of indoleamine 2,3-dioxygenase prolongs cardiac allograft survival by shaping the types of T-cell responses.
    Yu G; Dai H; Chen J; Duan L; Gong M; Liu L; Xiong P; Wang CY; Fang M; Gong F
    J Gene Med; 2008 Jul; 10(7):754-61. PubMed ID: 18452241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of indoleamine 2,3-dioxygenase in metastatic pancreatic ductal adenocarcinoma recruits regulatory T cells to avoid immune detection.
    Witkiewicz A; Williams TK; Cozzitorto J; Durkan B; Showalter SL; Yeo CJ; Brody JR
    J Am Coll Surg; 2008 May; 206(5):849-54; discussion 854-6. PubMed ID: 18471709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosmarinic acid inhibits indoleamine 2,3-dioxygenase expression in murine dendritic cells.
    Lee HJ; Jeong YI; Lee TH; Jung ID; Lee JS; Lee CM; Kim JI; Joo H; Lee JD; Park YM
    Biochem Pharmacol; 2007 May; 73(9):1412-21. PubMed ID: 17229401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COX-2 and PGE2 signaling is essential for the regulation of IDO expression by curcumin in murine bone marrow-derived dendritic cells.
    Jung ID; Jeong YI; Lee CM; Noh KT; Jeong SK; Chun SH; Choi OH; Park WS; Han J; Shin YK; Kim HW; Yun CH; Park YM
    Int Immunopharmacol; 2010 Jul; 10(7):760-8. PubMed ID: 20399909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of fish oil and corn oil diets on prostaglandin-dependent and myelopoiesis-associated immune suppressor mechanisms of mice bearing metastatic Lewis lung carcinoma tumors.
    Young MR; Young ME
    Cancer Res; 1989 Apr; 49(8):1931-6. PubMed ID: 2522813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXP3+ regulatory T cells and tumoral indoleamine 2,3-dioxygenase expression predicts the carcinogenesis of intraductal papillary mucinous neoplasms of the pancreas.
    Kobayashi N; Kubota K; Kato S; Watanabe S; Shimamura T; Kirikoshi H; Saito S; Ueda M; Endo I; Inayama Y; Maeda S; Nakajima A
    Pancreatology; 2010; 10(5):631-40. PubMed ID: 21051918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of indoleamine 2,3-dioxygenase in human endometrial carcinoma cells induces rapid tumor growth in a mouse xenograft model.
    Yoshida N; Ino K; Ishida Y; Kajiyama H; Yamamoto E; Shibata K; Terauchi M; Nawa A; Akimoto H; Takikawa O; Isobe K; Kikkawa F
    Clin Cancer Res; 2008 Nov; 14(22):7251-9. PubMed ID: 19010841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased indoleamine 2,3-dioxygenase expression in dendritic cells and role of indoleamine 2,3-dioxygenase-expressing dendritic cells in immune thrombocytopenia.
    Xu SQ; Wang CY; Zhu XJ; Dong XY; Shi Y; Peng J; Qin P; Sun JZ; Guo C; Ni H; Hou M
    Ann Hematol; 2012 Oct; 91(10):1623-31. PubMed ID: 22526360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis of murine lupus T cells induced by the selective cyclooxygenase-2 inhibitor celecoxib: molecular mechanisms and therapeutic potential.
    Yang P; Zhang Y; Ping L; Gao XM
    Int Immunopharmacol; 2007 Nov; 7(11):1414-21. PubMed ID: 17761345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of glioblastoma radioresponse by a selective COX-2 inhibitor celecoxib: inhibition of tumor angiogenesis with extensive tumor necrosis.
    Kang KB; Wang TT; Woon CT; Cheah ES; Moore XL; Zhu C; Wong MC
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):888-96. PubMed ID: 17293239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerogenic dendritic cells transferring hyporesponsiveness and synergizing T regulatory cells in transplant tolerance.
    Li M; Zhang X; Zheng X; Lian D; Zhang ZX; Sun H; Suzuki M; Vladau C; Huang X; Xia X; Zhong R; Garcia B; Min WP
    Int Immunol; 2008 Feb; 20(2):285-93. PubMed ID: 18182381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.